(Q39402779)

11 September 2017

title

CTLA4 mediated targeting enhances immunogenicity against PRRSV in a DNA prime/killed virus boost strategy (English)

1 reference

11 September 2017

Yalan Wang

1

1 reference

11 September 2017

Haiyan Zhao

2

1 reference

11 September 2017

Zhitao Ma

3

1 reference

11 September 2017

Yongqiang Wang

4

1 reference

11 September 2017

Wen-hai Feng

5

1 reference

11 September 2017

publication date

17 May 2013

1 reference

Veterinary Immunology and Immunopathology

11 September 2017

published in

1 reference

11 September 2017

volume

154

1 reference

11 September 2017

issue

3-4

1 reference

11 September 2017

page(s)

121-128

1 reference

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

inferred from DOI database lookup

7 January 2021

based on heuristic

CD40 ligand expressed in adenovirus can improve the immunogenicity of the GP3 and GP5 of porcine reproductive and respiratory syndrome virus in swine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Molecular characterization of porcine reproductive and respiratory syndrome virus, a member of the arterivirus group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Current knowledge on the structural proteins of porcine reproductive and respiratory syndrome (PRRS) virus: comparison of the North American and European isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

An evaluation of ultraviolet light (UV254) as a means to inactivate porcine reproductive and respiratory syndrome virus on common farm surfaces and materials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Effect of virus-specific antibodies on attachment, internalization and infection of porcine reproductive and respiratory syndrome virus in primary macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Discovery of a small arterivirus gene that overlaps the GP5 coding sequence and is important for virus production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Porcine reproductive and respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

A recombinant plasmid co-expressing swine ubiquitin and the GP5 encoding-gene of porcine reproductive and respiratory syndrome virus induces protective immunity in piglets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Enhanced immune responses of mice inoculated recombinant adenoviruses expressing GP5 by fusion with GP3 and/or GP4 of PRRS virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime/protein boost strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Emergence of a highly pathogenic porcine reproductive and respiratory syndrome virus in the Mid-Eastern region of China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Immunogenicity of the highly pathogenic porcine reproductive and respiratory syndrome virus GP5 protein encoded by a synthetic ORF5 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Immune response during coccidiosis in SC and FP chickens. I. In vitro assessment of T cell proliferation response to stage-specific parasite antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

CpG motif acts as a 'danger signal' and provides a T helper type 1-biased microenvironment for DNA vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Role of neutralizing antibodies in PRRSV protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Heterologous prime-boost vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Enhancement of gp120-Specific Immune Responses by Genetic Vaccination with the Human Immunodeficiency Virus Type 1 Envelope Gene Fused to the Gene Coding for Soluble CTLA4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Reversion of a live porcine reproductive and respiratory syndrome virus vaccine investigated by parallel mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Porcine reproductive and respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Gene gun immunization in a preclinical model is enhanced by B7 targeting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Emergence of fatal PRRSV variants: unparalleled outbreaks of atypical PRRS in China and molecular dissection of the unique hallmark

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Highly pathogenic porcine reproductive and respiratory syndrome, China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Development of an experimental inactivated PRRSV vaccine that induces virus-neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Identification of immunodominant T-cell epitopes present in glycoprotein 5 of the North American genotype of porcine reproductive and respiratory syndrome virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Porcine CTLA4-Ig lacks a MYPPPY motif, binds inefficiently to human B7 and specifically suppresses human CD4+ T cell responses costimulated by pig but not human B7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Heterologous HA DNA vaccine prime--inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

GM-CSF fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus increased the immune responses and protective efficacy against virulent PRRSV challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Jump-starting the immune system: prime-boosting comes of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Augmented humoral and cellular immune responses of a hepatitis B DNA vaccine encoding HBsAg by protein boosting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Highly virulent porcine reproductive and respiratory syndrome virus emerged in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: Implication of its potential use as a therapeutic vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2013.05.008

10.1016/J.VETIMM.2013.05.008

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference